News & Analysis as of

New Legislation Trump Administration Presidential Nominations

Alston & Bird

Look Ahead to the Week of July 7, 2025: GOP Returns Triumphant Following Enactment of ‘Big, Beautiful’ Bill

Alston & Bird on

The Senate is in session this week, but the House was granted an unscheduled recess week after narrowly passing the One Big Beautiful Bill Act before July 4 (H.R. 1). President Trump signed the bill into law over the weekend,...more

Latham & Watkins LLP

Week 11 in Review: Wide-Ranging Tariffs, More Lawsuits, and Personnel Moves

Latham & Watkins LLP on

The Trump administration imposes additional wide-ranging tariffs as legal challenges to the administration’s actions continue....more

Holland & Knight LLP

Holland & Knight Health Dose: April 2, 2025

Holland & Knight LLP on

Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector....more

McDermott+

McDermott+ Check-Up: March 28, 2025

McDermott+ on

Senate Confirms FDA, NIH Nominations, Advances CMS Nomination. On March 25, 2025, the Senate confirmed Martin Makary, MD, as the next FDA commissioner by a 56 – 44 vote. Sens. Durbin (D-IL), Hassan (D-NH), and Shaheen (D-NH)...more

Alston & Bird

Look Ahead to the Week of January 27: House Republicans in Florida to Strategize with Trump

Alston & Bird on

The Senate is in session this week, but the House will not hold votes. House Republicans are gathering at Trump National Doral in Florida for their annual issues retreat starting Monday. A significant portion of the three-day...more

5 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide